Consumption of broccoli sprouts during late gestation and lactation confers protection against developmental delay

Antoinette T Nguyen1, Ashley M A Bahry1, Ke Qin Shen1

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Insights

Dietary broccoli sprout supplementation may prevent fetal inflammatory response-induced neurodevelopmental issues. This study shows broccoli sprouts (BrSp) can mitigate growth restriction and behavioral delays in a rodent model.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Fetal inflammatory response is a known risk factor for cerebral palsy.
  • Currently, no preventive therapies exist for this condition.
  • Broccoli sprouts (BrSp) are a potent inducer of phase-II detoxification enzymes.

Purpose of the Study:

  • To investigate the efficacy of dietary broccoli sprout (BrSp) supplementation in preventing behavioral and pathological outcomes associated with fetal inflammation.
  • To assess BrSp's potential as a preventive therapy against inflammation-induced neurodevelopmental deficits.

Main Methods:

  • Pregnant rats were exposed to lipopolysaccharide (LPS) to induce inflammation on embryonic days 19 and 20.
  • Broccoli sprout (BrSp) supplementation was administered to dams from embryonic day 14 through postnatal day 21.
  • Offspring underwent neurodevelopmental reflex testing and neuropathological analyses.

Main Results:

  • LPS-exposed pups exhibited significant growth restriction and delays in motor reflexes (hindlimb placing, cliff avoidance, gait).
  • Behavioral analysis revealed increased grooming and reduced center-box exploration in LPS pups.
  • BrSp supplementation improved birth weight, normalized neurodevelopmental reflexes, and reduced abnormal grooming in LPS-exposed offspring.

Conclusions:

  • Dietary BrSp supplementation during pregnancy shows promise in preventing fetal inflammation-induced growth restriction.
  • BrSp may be an effective strategy to mitigate neurodevelopmental delays and behavioral abnormalities in offspring exposed to prenatal inflammation.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
9
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
30
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
9
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K